As of Mar 16
| -0.35 / -2.80%|
The 1 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a -1.23% decrease from the last price of 12.15.
The current consensus among 2 polled investment analysts is to Buy stock in Juniper Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.